Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)
26.30
-0.55 (-2.05%)
Sep 17, 2025, 1:55 PM CST
Genomics BioSci & Tech. Market Cap
Genomics BioSci & Tech. has a market cap or net worth of 1.95 billion as of September 16, 2025. Its market cap has increased by 38.40% in one year.
Market Cap
1.95B
Enterprise Value
2.44B
Revenue
563.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.30
Market Cap Chart
Since December 16, 2013, Genomics BioSci & Tech.'s market cap has increased from 1.58B to 1.95B, an increase of 23.03%. That is a compound annual growth rate of 1.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 16, 2025 | 1.95B | 39.84% |
Dec 31, 2024 | 1.39B | -7.69% |
Dec 29, 2023 | 1.51B | 19.84% |
Dec 30, 2022 | 1.26B | 11.67% |
Dec 30, 2021 | 1.13B | 0.78% |
Dec 31, 2020 | 1.12B | 50.19% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Caliway Biopharmaceuticals | 307.10B |
PharmaEssentia | 181.77B |
Bora Pharmaceuticals Co., LTD. | 88.24B |
Lumosa Therapeutics | 53.74B |
Lotus Pharmaceutical | 48.91B |
Oneness Biotech | 33.67B |
Polaris Group | 28.70B |
Center Laboratories | 27.67B |